Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.
Am J Hematol
; 97(1): E27-E31, 2022 01 01.
Article
in English
| MEDLINE | ID: covidwho-1516712
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
Immunoglobulin Light-chain Amyloidosis
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Hematol
Year:
2022
Document Type:
Article
Affiliation country:
Ajh.26406
Similar
MEDLINE
...
LILACS
LIS